{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:11:14Z","timestamp":1782137474267,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"NIDA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.drugalcdep.2022.109403","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T16:55:57Z","timestamp":1647276957000},"page":"109403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder"],"prefix":"10.1016","volume":"234","author":[{"given":"Irene","family":"Pericot-Valverde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moonseong","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Rennert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna L.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Arnsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.drugalcdep.2022.109403_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cld.2017.03.007","article-title":"Chronic Hepatitis C virus infection and depression","volume":"21","author":"Adinolfi","year":"2017","journal-title":"Clin. Liver Dis."},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109403_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12879-018-2964-5","article-title":"Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy","volume":"18","author":"Akiyama","year":"2018","journal-title":"BMC Infect. Dis."},{"issue":"9","key":"10.1016\/j.drugalcdep.2022.109403_bib3","doi-asserted-by":"crossref","first-page":"594","DOI":"10.7326\/M18-1715","article-title":"Intensive models of Hepatitis C care for people who inject drugs receiving opioid agonist therapy: a randomized controlled trial","volume":"170","author":"Akiyama","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.drugalcdep.2022.109403_bib4","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/liv.14313","article-title":"Efficacy and safety of Elbasvir\/grazoprevir for 8 or 12 weeks for Hepatitis C virus genotype 4 infection: a randomized study","volume":"40","author":"Asselah","year":"2020","journal-title":"Liver Int"},{"issue":"8","key":"10.1016\/j.drugalcdep.2022.109403_bib5","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jvh.13110","article-title":"Efficacy and safety of glecaprevir\/pibrentasvir in patients with chronic HCV infection and psychiatric disorders: an integrated analysis","volume":"26","author":"Back","year":"2019","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.drugalcdep.2022.109403_bib6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.drugalcdep.2022.109403_bib7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/liv.14266","article-title":"Adherence to pan-genotypic glecaprevir\/pibrentasvir and efficacy in HCV-infected patients: a pooled analysis of clinical trials","volume":"40","author":"Brown","year":"2020","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109403_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14423\/SMJ.0000000000000750","article-title":"Measuring adherence to Hepatitis C direct-acting antiviral medications: using the VAS in an HCV treatment clinic","volume":"111","author":"Burton","year":"2018","journal-title":"South Med. J."},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109403_bib9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2648.2008.04641.x","article-title":"Stigma in the context of Hepatitis C: concept analysis","volume":"62","author":"Butt","year":"2008","journal-title":"J. Adv. Nurs."},{"issue":"2\u20133","key":"10.1016\/j.drugalcdep.2022.109403_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2006.09.002","article-title":"Initial evidence for the reliability and validity of a \u201cLite\u201d version of the Addiction Severity Index","volume":"87","author":"Cacciola","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2022.109403_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107793","article-title":"Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: a systematic review and meta-analysis","volume":"207","author":"Colledge","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109403_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.genhosppsych.2011.09.002","article-title":"Screening inventories to detect depression in chronic Hepatitis C patients","volume":"34","author":"F\u00e1bregas","year":"2012","journal-title":"Gen. Hosp. Psychiatry"},{"issue":"12","key":"10.1016\/j.drugalcdep.2022.109403_bib13","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1016\/j.socscimed.2006.08.005","article-title":"Illness-related stigma, mood and adjustment to illness in persons with Hepatitis C","volume":"63","author":"Golden","year":"2006","journal-title":"Soc. Sci. Med."},{"issue":"3","key":"10.1016\/j.drugalcdep.2022.109403_bib14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.addbeh.2013.11.022","article-title":"Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: systematic review and meta-analyses","volume":"39","author":"Goldner","year":"2014","journal-title":"Addict. Behav."},{"issue":"2","key":"10.1016\/j.drugalcdep.2022.109403_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/jurban\/jth114","article-title":"Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the beck depression inventory","volume":"81","author":"Golub","year":"2004","journal-title":"J. Urban Health"},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109403_bib16","first-page":"445","article-title":"Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents","volume":"111","author":"Go\u00f1i Esarte","year":"2019","journal-title":"Rev. Esp. Enferm. Dig."},{"issue":"2\u20133","key":"10.1016\/j.drugalcdep.2022.109403_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.drugalcdep.2009.09.015","article-title":"Factors associated with uptake of treatment for recent Hepatitis C virus infection in a predominantly injecting drug user cohort: the ATAHC study","volume":"107","author":"Grebely","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"15","key":"10.1016\/j.drugalcdep.2022.109403_bib18","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.4254\/wjh.v7.i15.1921","article-title":"Psychiatric and substance use disorders co-morbidities and Hepatitis C: diagnostic and treatment implications","volume":"7","author":"Hauser","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.drugalcdep.2022.109403_bib19","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab334","article-title":"Hepatitis C virus direct-acting antiviral treatment adherence patterns and sustained viral response among people who inject drugs treated in opioid agonist therapy programs","author":"Heo","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.drugalcdep.2022.109403_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205277","article-title":"Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic Hepatitis C patients","volume":"13","author":"Juanbeltz","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109403_bib21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0165-0327(99)00088-9","article-title":"The use of the Beck depression inventory to screen for depression in the general population: a preliminary analysis","volume":"57","author":"Lasa","year":"2000","journal-title":"J. Affect Disord."},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109403_bib22","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/070674371105600607","article-title":"Risk indicators of depressive symptomatology among injection drug users and increased HIV risk behaviour","volume":"56","author":"Lemstra","year":"2011","journal-title":"Can. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.drugalcdep.2022.109403_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10461-018-2318-8","article-title":"Depressive symptoms at HIV testing and two-year all-cause mortality among men who inject drugs in Vietnam","volume":"Mar;23","author":"Levintow","year":"2019","journal-title":"AIDS Behav."},{"issue":"Supplement_5","key":"10.1016\/j.drugalcdep.2022.109403_bib24","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1093\/infdis\/jiaa432","article-title":"Infectious diseases and injection drug use: public health burden and response","volume":"222","author":"Levitt","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"sup2","key":"10.1016\/j.drugalcdep.2022.109403_bib25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/09540121.2020.1739209","article-title":"HCV infection status and care seeking among people living with HIV who use drugs in Vietnam","volume":"32","author":"Li","year":"2020","journal-title":"AIDS Care"},{"issue":"40","key":"10.1016\/j.drugalcdep.2022.109403_bib26","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.3748\/wjg.v19.i40.6703","article-title":"Hepatitis C, stigma and cure","volume":"19","author":"Marinho","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.drugalcdep.2022.109403_bib27","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.drugpo.2017.05.025","article-title":"Understanding real-world adherence in the directly acting antiviral era: A prospective evaluation of adherence among people with a history of drug use at a community-based program in Toronto, Canada","volume":"47","author":"Mason","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2022.109403_bib28","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2147\/PPA.S49113","article-title":"Factors associated with uptake, adherence, and efficacy of Hepatitis C treatment in people who inject drugs: a literature review","volume":"7","author":"Mrav\u010d\u00edk","year":"2013","journal-title":"Patient Prefer Adherence"},{"issue":"9791","key":"10.1016\/j.drugalcdep.2022.109403_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.drugalcdep.2022.109403_bib30","doi-asserted-by":"crossref","first-page":"ofaa377","DOI":"10.1093\/ofid\/ofaa377","article-title":"Low adherence achieves high HCV cure rates among people who inject drugs treated with direct-acting antiviral agents","volume":"7","author":"Norton","year":"2020","journal-title":"Open Forum Infect. Dis."},{"issue":"3","key":"10.1016\/j.drugalcdep.2022.109403_bib31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.drugalcdep.2013.04.007","article-title":"The role of depression and social support in non-fatal drug overdose among a cohort of injection drug users in a Canadian setting","volume":"132","author":"Pabayo","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.drugalcdep.2022.109403_bib32","doi-asserted-by":"crossref","first-page":"ofaa380","DOI":"10.1093\/ofid\/ofaa380","article-title":"Declines in depressive symptoms among people who inject drugs treated with direct-acting antivirals while on opioid agonist therapy","volume":"7","author":"Pericot-Valverde","year":"2020","journal-title":"Open Forum Infect. Dis."},{"issue":"2","key":"10.1016\/j.drugalcdep.2022.109403_bib33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12072-015-9680-7","article-title":"High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a Phase 2a study","volume":"10","author":"Petersen","year":"2016","journal-title":"Hepatol. Int."},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109403_bib34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3109\/00952990903544802","article-title":"Gender differences in social support and depression among injection drug users in Houston, Texas","volume":"36","author":"Risser","year":"2010","journal-title":"Am. J. Drug Alcohol Abus."},{"issue":"Suppl 20","key":"10.1016\/j.drugalcdep.2022.109403_bib35","first-page":"34","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.drugalcdep.2022.109403_bib36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/hiv.12726","article-title":"Depression and all-cause mortality risk in HIV-infected and HIV-uninfected US veterans: a cohort study","volume":"May;20","author":"So-Armah","year":"2019","journal-title":"HIV Med."},{"key":"10.1016\/j.drugalcdep.2022.109403_bib37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.drugpo.2017.05.045","article-title":"Healthcare contact and treatment uptake following Hepatitis C virus screening and counseling among rural Appalachian people who use drugs","volume":"47","author":"Stephens","year":"2017","journal-title":"Int. J. Drug Policy"},{"issue":"1","key":"10.1016\/j.drugalcdep.2022.109403_bib38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12888-018-1735-6","article-title":"Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study","volume":"18","author":"Sundberg","year":"2018","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.drugalcdep.2022.109403_bib39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/cid\/ciy899","article-title":"Integrated, co-located, Telemedicine-based treatment approaches for Hepatitis C virus management in opioid use disorder patients on methadone","volume":"69","author":"Talal","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"31","key":"10.1016\/j.drugalcdep.2022.109403_bib40","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.4254\/wjh.v8.i31.1318","article-title":"Safe and effective sofosbuvir-based therapy in patients with mental health disease on Hepatitis C virus treatment","volume":"8","author":"Tang","year":"2016","journal-title":"World J. Hepatol."},{"issue":"6","key":"10.1016\/j.drugalcdep.2022.109403_bib41","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/add.12860","article-title":"Long-term mortality, remission, criminality and psychiatric comorbidity of heroin dependence: 11-year findings from the Australian treatment outcome study","volume":"110","author":"Teesson","year":"2015","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugalcdep.2022.109403_bib42","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/jurban\/jtg025","article-title":"The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore, Maryland","volume":"80","author":"Tobin","year":"2003","journal-title":"J. Urban Health"},{"issue":"8","key":"10.1016\/j.drugalcdep.2022.109403_bib43","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4088\/JCP.12r07694","article-title":"Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis","volume":"73","author":"Udina","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2022.109403_bib44","article-title":"Non-adherence to LDV\/SOF did not predict SVR in a randomized controlled trial of HIV\/HCV coinfected persons who use drugs","author":"Ward","year":"2021","journal-title":"J. Infect. Dis."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871622001405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871622001405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:20:16Z","timestamp":1759828816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871622001405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":44,"alternative-id":["S0376871622001405"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109403","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between depressive symptoms and adherence to direct-acting antivirals: Implications for Hepatitis C treatment among people who inject drugs on medications for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109403"}}